In the H69 tumor-bearing mouse model, all therapies showed a trend towards a reduced growth rate compared to the untreated tumors.
← all excerpts
Combining [<sup>177</sup>Lu]Lu-DOTA-TOC PRRT with PARP inhibitors to enhance treatment efficacy in small cell lung cancer.
1
—
—